Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-11-8
pubmed:abstractText
Angiotensin converting enzyme (ACE) inhibitors significantly improve survival in patients with atherosclerosis. Although ACE inhibitors reduce local angiotensin II (AngII) formation, serine proteases form AngII to an enormous amount independently from ACE. Therefore, our study concentrates on the effect of the ACE-inhibitor ramiprilat on chemokine release, AngII receptor (ATR) expression, and NF-kappaB activity in monocytes stimulated with AngII.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 2 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/CCL2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2, http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8, http://linkedlifedata.com/resource/pubmed/chemical/Losartan, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/PD 123319, http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Ramipril, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 2, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/ramiprilat
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-291X
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
325
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
532-40
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15530425-Angiotensin II, pubmed-meshheading:15530425-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:15530425-Angiotensin II Type 2 Receptor Blockers, pubmed-meshheading:15530425-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15530425-Cell Line, pubmed-meshheading:15530425-Chemokine CCL2, pubmed-meshheading:15530425-Chemokines, pubmed-meshheading:15530425-Down-Regulation, pubmed-meshheading:15530425-Drug Interactions, pubmed-meshheading:15530425-Endothelium, Vascular, pubmed-meshheading:15530425-Humans, pubmed-meshheading:15530425-Imidazoles, pubmed-meshheading:15530425-Interleukin-8, pubmed-meshheading:15530425-Losartan, pubmed-meshheading:15530425-Monocytes, pubmed-meshheading:15530425-NF-kappa B, pubmed-meshheading:15530425-Peptidyl-Dipeptidase A, pubmed-meshheading:15530425-Pyridines, pubmed-meshheading:15530425-RNA, Messenger, pubmed-meshheading:15530425-Ramipril, pubmed-meshheading:15530425-Receptor, Angiotensin, Type 1, pubmed-meshheading:15530425-Receptor, Angiotensin, Type 2, pubmed-meshheading:15530425-Simvastatin, pubmed-meshheading:15530425-Umbilical Veins
pubmed:year
2004
pubmed:articleTitle
ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
pubmed:affiliation
Medical Clinic II, University of Technology, Dresden, Germany. AlexanderSchmeis@t-online.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't